Stock listing
13 Stock Price, News, Filings & Events — Hutchmed (china) Limited
Selected listing: 13 · HKEX · HKD · HK
This page tracks Hutchmed (china) Limited's 13:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 13:HKEX. 13:HKEX is the stock-level entry point for investors researching Hutchmed (china) Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hutchmed (China) Limited is a public company traded on the Hong Kong Stock Exchange under the ticker symbol 13. The company has a market capitalization of approximately HKD 1.97 billion. Hutchmed focuses on the development and commercialization of innovative medicines for the treatment of cancer and other serious diseases.
- Ticker
- 13:HKEX
- Asset type
- Stock
- Market cap
- $2.42B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD
Hutchmed (china) Limited 13:HKEX stock context
This page tracks Hutchmed (china) Limited's 13:HKEX listing on HKEX in HKD for HK, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 13:HKEX. 13:HKEX is the stock-level entry point for investors researching Hutchmed (china) Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Hutchmed (China) Limited is a public company traded on the Hong Kong Stock Exchange under the ticker symbol 13. The company has a market capitalization of approximately HKD 1.97 billion. Hutchmed focuses on the development and commercialization of innovative medicines for the treatment of cancer and other serious diseases.
Latest news from Hutchmed (china) Limited
HUTCHMED Announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy
September 3, 2026
HUTCHMED Reports 2026 Interim Results
July 30, 2026
HUTCHMED to Announce 2026 Half-Year Financial Results
June 30, 2026
HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma
May 21, 2026
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
April 29, 2026
Hutchmed (china) Limited earnings calls
HUTCHMED (China) Limited (HCM) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q4 2025 Earnings Call
March 5, 2026 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q3 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q4 2024 Earnings Call
March 19, 2025 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q2 2024 Earnings Call
July 31, 2024 · Replay with transcript and chapters
HUTCHMED (China) Limited (HCM) Q4 2023 Earnings Call
February 28, 2024 · Replay with transcript and chapters
Research Hutchmed (china) Limited
Hutchmed (china) Limited investor report
Review AI stock analysis and investor report context for 13:HKEX.
Hutchmed (china) Limited company profile
View the public company page for Hutchmed (china) Limited on 6ix.
Hutchmed (china) Limited news
Read company news and market updates connected to Hutchmed (china) Limited.
Hutchmed (china) Limited investor events
Find investor webinars, events, and replay context for Hutchmed (china) Limited.
Alternate listings
HCM:NASDAQ
US · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
HCM:LSE
GB · GBX
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
H7T2:GETTEX
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
A2PJ5B:LSX
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
HCM:BOATS
US · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
A2PJ5B:LS
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
HMDCF:OTC
US · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
0J7G:LSE
GB · USD
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
HCML:AQUISUK
GB · GBX
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
H7T1:GETTEX
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
HCM.GB:AQUIS
GB · GBX
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.
H7T1:DUS
DE · EUR
Alternate listing for Hutchmed (china) Limited; the primary context on this page is 13:HKEX.